| Suzanne Saindon, DO | |
|
63 Park Street, Andover, MA 01810-3662 | |
| (978) 409-1137 | |
| (978) 409-1906 |
| Full Name | Suzanne Saindon |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 63 Park Street, Andover, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831485341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 248848 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Accentcare Home Health Of Massachusetts | Westwood, MA | Home health agency |
| Holy Family Hospital | Methuen, MA | Hospital |
| Lawrence General Hospital | Lawrence, MA | Hospital |
| Parkland Medical Center | Derry, NH | Hospital |
| Winchester Hospital | Winchester, MA | Hospital |
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Care Of Boston Management Corporation | 6800787714 | 234 |
News Archive
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
Iron deficiency is the most common nutritional deficiency in the world and causes long-term adverse consequences in children.
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
› Verified 4 days ago
| Entity Name | Medical Care Of Boston Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437196359 PECOS PAC ID: 6800787714 Enrollment ID: O20040322000778 |
News Archive
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
Iron deficiency is the most common nutritional deficiency in the world and causes long-term adverse consequences in children.
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
› Verified 4 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
Iron deficiency is the most common nutritional deficiency in the world and causes long-term adverse consequences in children.
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
› Verified 4 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
Iron deficiency is the most common nutritional deficiency in the world and causes long-term adverse consequences in children.
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Suzanne Saindon, DO 63 Park Street, Andover, MA 01810-3662 Ph: (978) 409-1137 | Suzanne Saindon, DO 63 Park Street, Andover, MA 01810-3662 Ph: (978) 409-1137 |
News Archive
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression.
Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.
Iron deficiency is the most common nutritional deficiency in the world and causes long-term adverse consequences in children.
Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
› Verified 4 days ago
Madhavi Challagulla, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 323 Lowell St, Andover, MA 01810 Phone: 978-783-5000 Fax: 978-313-8184 | |
Phyllis Spieler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 Haverhill St, Suite 102, Andover, MA 01810 Phone: 978-470-1902 Fax: 978-749-3605 | |
Dr. Spyridon Kantas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Park Street, Andover, MA 01810 Phone: 978-409-1137 Fax: 978-409-1906 | |
Paul N Lemaitre, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 Haverhill St, Suite 203, Andover, MA 01810 Phone: 978-475-7765 Fax: 978-662-2239 | |
Alida Melisa Rosado Rodriguez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 323 Lowell St, Andover, MA 01810 Phone: 978-783-5000 Fax: 978-313-8182 | |
Constance L Williams, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Unicare- 200 Brickstone Square, Suite #101, Andover, MA 01810 Phone: 978-474-6816 | |
Dr. Chiochen Cheng, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 133 Bailey Rd, Andover, MA 01810 Phone: 978-886-3978 |